JP2024522769A5 - - Google Patents
Info
- Publication number
- JP2024522769A5 JP2024522769A5 JP2023577713A JP2023577713A JP2024522769A5 JP 2024522769 A5 JP2024522769 A5 JP 2024522769A5 JP 2023577713 A JP2023577713 A JP 2023577713A JP 2023577713 A JP2023577713 A JP 2023577713A JP 2024522769 A5 JP2024522769 A5 JP 2024522769A5
- Authority
- JP
- Japan
- Prior art keywords
- weeks
- pharmaceutical composition
- composition according
- iptacopan
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163212465P | 2021-06-18 | 2021-06-18 | |
| US63/212,465 | 2021-06-18 | ||
| PCT/IB2022/055639 WO2022264101A1 (en) | 2021-06-18 | 2022-06-17 | Method of treating an autoimmune hematological disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522769A JP2024522769A (ja) | 2024-06-21 |
| JP2024522769A5 true JP2024522769A5 (https=) | 2025-06-04 |
Family
ID=82595001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577713A Pending JP2024522769A (ja) | 2021-06-18 | 2022-06-17 | 自己免疫性血液学的疾患を治療する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240277689A1 (https=) |
| EP (1) | EP4355329A1 (https=) |
| JP (1) | JP2024522769A (https=) |
| CN (1) | CN117500500A (https=) |
| WO (1) | WO2022264101A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021414253B2 (en) * | 2020-12-30 | 2024-05-16 | Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. | Series of piperidine-substituted benzoic acid compounds, and use thereof |
| US20250161347A1 (en) | 2023-11-22 | 2025-05-22 | Flagship Pioneering Innovations Vii, Llc | Methods and compositions for treating non-alcoholic fatty liver disease |
| WO2025148628A1 (zh) * | 2024-01-10 | 2025-07-17 | 河北以岭医药研究院有限公司 | 哌啶基吲哚衍生物及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3425B1 (ar) | 2013-07-15 | 2019-10-20 | Novartis Ag | مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b |
| CN120208923A (zh) | 2020-05-18 | 2025-06-27 | 诺华股份有限公司 | Lnp023的结晶形式 |
-
2022
- 2022-06-17 JP JP2023577713A patent/JP2024522769A/ja active Pending
- 2022-06-17 CN CN202280043007.4A patent/CN117500500A/zh active Pending
- 2022-06-17 US US18/569,432 patent/US20240277689A1/en active Pending
- 2022-06-17 EP EP22743562.5A patent/EP4355329A1/en active Pending
- 2022-06-17 WO PCT/IB2022/055639 patent/WO2022264101A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024522769A5 (https=) | ||
| JP2829545B2 (ja) | ２’３’―ジデオキシイノシンによるヒトのレトロウィルス感染症の治療 | |
| Shahar | Current therapeutic options in severe Guillain-Barre syndrome | |
| Gudbrandsdottir et al. | Combination of thrombopoietin receptor agonists, immunosuppressants and intravenous immunoglobulin as treatment of severe refractory immune thrombocytopenia in adults and children. | |
| Engqvist et al. | Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double-blind study | |
| Allan et al. | Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy | |
| JP2021517144A (ja) | Ｃｄ４７遮断療法およびｃｄ３８抗体の組み合わせ | |
| Pirofsky et al. | Intravenous immune globulins: a review of their uses in selected immunodeficiency and autoimmune diseases | |
| JP2021152002A5 (https=) | ||
| JP2008526848A (ja) | 黄色ブドウ球菌感染を治療する方法 | |
| JP2022514561A5 (https=) | ||
| AU2016259320A1 (en) | Pharmaceutical compositions | |
| JP2021522241A5 (https=) | ||
| RU2505312C2 (ru) | Комплексное лекарственное средство для лечения гриппа различных типов | |
| Aleem et al. | Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations (Archived) | |
| JP2023531722A5 (https=) | ||
| US20110301102A1 (en) | Compositions and methods for treating myelodysplastic syndrome | |
| US5656628A (en) | Use of L-acetylcarnitine for the treatment of AIDS | |
| WO2018091679A1 (en) | Combined cd6 and imipenem therapy for treatment of infectious diseases and related inflammatory processes | |
| RU2500422C2 (ru) | Комплексное лекарственное средство для лечения вирусных инфекций и способ лечения вирусных инфекций | |
| Aleem et al. | Evaluating And Referring Patients For Outpatient Monoclonal Antibody Therapy For Coronavirus In The Emergency Department (Archived) | |
| JP2023534576A5 (https=) | ||
| RU2473364C2 (ru) | Способ лечения клещевого энцефалита | |
| Hill et al. | Intravenous immune globulin use in newborns | |
| Bahrin et al. | Persistent immune thrombocytopenia resistant to immunosuppressive therapy: what is the way forward? |